Thanks to the phenomenal support of our friends in the contemporary art community, TWO x TWO for AIDS and Art’s annual benefit gala dinner and art auction has raised over $75 million in its 19-year history in support of amfAR’s AIDS research initiatives and the DMA’s contemporary art acquisition program.
amfAR, The Foundation for AIDS Research, founded in 1985, is dedicated to ending the global AIDS epidemic through innovative research. With the freedom and flexibility to respond quickly to emerging areas of scientific promise, amfAR plays a catalytic role in accelerating the pace of HIV/AIDS research and achieving real breakthroughs. Since its founding in1985, amfAR has invested more than $517 million in its programs and has awarded more than 3,300 grants to research teams worldwide. amfAR’s impact includes:
- In 2014, amfAR launched the “Countdown to a Cure for HIV/AIDS,” a $100 million research initiative aimed at developing the scientific basis of a cure by the end of 2020. To date, amfAR has awarded 60 Countdown grants totaling close to $50 million to support research conducted by more than 200 scientists working at 74 institutions in 10 countries.
- The centerpiece of the Countdown is the amfAR Institute for HIV Cure Research. Established in 2016 with a five-year, $20 million grant to the University of California, San Francisco, the Institute involves teams of researchers at UCSF and collaborating institutions pursing a range of cure-focused strategies. Institute researchers have initiated a series of clinical studies to test the effectiveness of experimental cure interventions.
- Previous amfAR-funded research studies have contributed to the development of four of the six primary classes of anti-HIV drugs (protease inhibitors, entry inhibitors, CCR5 blockers, and integrase inhibitors) that are helping people with HIV/AIDS live longer, healthier lives.
- amfAR pioneered the research that led to the use of drugs to prevent mother-to-child HIV transmission, which has resulted in the virtual elimination of such transmission in many parts of the world.
- Research supported by amfAR led to the identification of the critical role of the cell protein CCR5 in HIV infection—a pivotal finding that played an important part in the case of the “Berlin patient,” the only person known to have been cured of HIV.
- amfAR created and supports a consortium of European researchers that is working to determine and replicate the precise conditions that led to the Berlin patient’s cure.
- Launched in 2001, amfAR’s Bangkok-based TREAT Asia program is a network of hospitals, clinics, and research institutions working with civil society to ensure the safe and effective delivery of HIV/AIDS treatments across Asia and the Pacific. Encompassing 21 adult and 18 pediatric sites, TREAT Asia is widely regarded as a model of regional collaboration on HIV/AIDS.
- Through its public policy office, established in 1991, amfAR has worked with members of Congress to design and secure the passage of landmark AIDS-related legislation that has expanded access to treatment, care, and prevention, and has increased federal funding for AIDS research.
The Dallas Museum of Art, established in 1903, is among the 10 largest art museums in the country and is distinguished by its commitment to research, innovation and public engagement. At the heart of the Museum and its programs is its global collection, which encompasses more than 24,000 works and spans 5,000 years of history, representing a full range of world cultures. Located in the nation’s largest arts district, the Museum acts as a catalyst for community creativity, engaging people of all ages and backgrounds with a diverse spectrum of programming, from exhibitions and lectures to concerts, literary events, and dramatic and dance presentations. Since the Museum’s return to free general admission in 2013, the DMA has welcomed more than two and a half million visitors. For more information, visit dma.org.
- The transformative impact that the TWO x TWO initiative has had in shaping the quality and depth of the DMA’s contemporary holdings includes the acquisition of more than 260 artworks. Among them are significant paintings, sculpture, media, photographs, drawings, and prints by the finest and most ambitious artists of our time, such as Frank Bowling, Walter De Maria, Julie Mehretu, Bruce Nauman, Laura Owens, Sigmar Polke, Jackson Pollock, Charles Ray, Gerhard Richter, Joan Semmel, Keith Sonnier, Haim Steinbach, and Rebecca Warren.
- The Dallas Museum of Art made history in 2013 with its return to free general admission. Recent acclaimed special exhibitions made possible by TWO x TWO for AIDS and Art include:
Truth: 24 frames per second
Yayoi Kusama: All the Eternal Love I Have for the Pumpkins
Carey Young: The New Architecture
Walter De Maria: Counterpoint
Nicolas Party: Pathway
Rebecca Warren: The Main Feeling
Jackson Pollock: Blind Spots
NS Harsha: Sprouts reach in to reach out
Frank Bowling: Map Paintings
Michaël Borremans: As sweet as it gets
Mirror Stage, Visualizing the Self after the Internet
Between Action and the Unknown: The Art of Kazuo Shiraga and Sadamasa Motonaga
Isa Genzken: Retrospective
Robert Smithson in Texas
Jim Hodges: Give more than you take
- The Concentrations series began in 1981 as a part of the DMA’s commitment to showcase the work of underrepresented and emerging living artists. Through the series of project-based exhibitions, the Museum has proudly featured the work of over 50 artists, providing many of them their first US museum solo exhibition. For the past 20 years, TWO x TWO for AIDS and Art has provided support for these large scale installations by artists such as Doug Aitken, Karla Black, Matt Connors, Willie Doherty, Maureen Gallace, Charline von Heyl, Chosil Kil, Shirin Neshat, Richard Patterson, Anri Sala, and Slavs and Tatars.
Learn more about TWO x TWO event revenue to the DMA.